Poster – Novel Image Analysis And IHC Advances For NASH
Global prevalence of non-alcoholic fatty liver disease (NAFLD) is 25.24% in 2016,…
Read more
Webinar – Cytek Aurora Instrument Standardization For Patient Testing In Global Clinical Trials
Recently Cerba Research’s Regional Head of Flow Cytometry, Veronica Nash, PhD, presented…
Read more
White Paper – Precision Medicine For Non-Small Cell Lung Cancer (NSCLC) – Emerging Trends In Molecular Analysis
Of all types of cancer, lung cancer caused more deaths worldwide than…
Read more
Poster – CYTO 2023 Poster Pack
Comparison of BD FACSLyric™ Instrument Performance in a Global Setting As flow…
Read more
Cerba Xpert – ISO 9001:2015
Read more
Agrément CIR – Cerba Xpert
Expenses incurred by a company in research or innovation operations, entrusted to…
Read more
Agrément CIR – Histalim
Expenses incurred by a company in research or innovation operations, entrusted to…
Read more
Together, we can shape the future of your clinical development. Find out more about how we can support your research.